An efficient computational protocol for template‐based design of peptides that inhibit interactions involving SARS‐CoV‐2 proteins.

The RNA‐dependent RNA polymerase (RdRp) complex of SARS‐CoV‐2 lies at the core of its replication and transcription processes. The interfaces between holo‐RdRp subunits are highly conserved, facilitating the design of inhibitors with high affinity for the interaction interface hotspots. We, therefore, take this as a model protein complex for the application of a structural bioinformatics protocol to design peptides that inhibit RdRp complexation by preferential binding at the interface of its core subunit nonstructural protein, nsp12, with accessory factor nsp7. Here, the interaction hotspots of the nsp7‐nsp12 subunit of RdRp, determined from a long molecular dynamics trajectory, are used as a template. A large library of peptide sequences constructed from multiple hotspot motifs of nsp12 is screened in‐silico to determine sequences with high geometric complementarity and interaction specificity for the binding interface of nsp7 (target) in the complex. Two lead designed peptides are extensively characterized using orthogonal bioanalytical methods to determine their suitability for inhibition of RdRp complexation. Binding affinity of these peptides to accessory factor nsp7, determined using a surface plasmon resonance (SPR) assay, is slightly better than that of nsp12: dissociation constant of 133nM and 167nM, respectively, compared to 473nM for nsp12. A competitive ELISA is used to quantify inhibition of nsp7‐nsp12 complexation, with one of the lead peptides giving an IC50 of 25μM. Cell penetrability and cytotoxicity are characterized using a cargo delivery assay and MTT cytotoxicity assay, respectively. Overall, this work presents a proof‐of‐concept of an approach for rational discovery of peptide inhibitors of SARS‐CoV‐2 protein–protein interactions. [ABSTRACT FROM AUTHOR]